Predictors of analgesic efficacy of neurolytic celiac plexus block in patients with unresectable pancreatic cancer: the importance of timing
- 17 January 2018
- journal article
- research article
- Published by Springer Nature in Supportive Care in Cancer
- Vol. 26 (6) , 2023-2030
Abstract
Neurolytic celiac plexus block (NCPB) is a safe and effective method for reducing abdominal cancer pain. However, the analgesic efficacy of NCPB is not always guaranteed. The aim of this retrospective study was to identify predictors for the analgesic efficacy of NCPB in patients with unresectable pancreatic cancer.Keywords
This publication has 28 references indexed in Scilit:
- Painful Boney MetastasesThe Korean Journal of Pain, 2013
- The Effectiveness of Repeat Celiac Plexus Neurolysis for Pancreatic Cancer: A Pilot StudyPain Practice, 2012
- PREDICTIVE FACTORS FOR PAIN RELIEF AFTER ENDOSCOPIC ULTRASOUND-GUIDED CELIAC PLEXUS NEUROLYSISDigestive Endoscopy, 2010
- Assessment of Celiac Plexus Block and Neurolysis Outcomes and Technique in the Management of Refractory Visceral Cancer PainPain Medicine, 2010
- The cognitive effects of opioids in cancer: a systematic reviewSupportive Care in Cancer, 2008
- CA 19-9 Response as an Early Indicator of the Effectiveness of Gemcitabine in Patients with Advanced Pancreatic CancerOncology, 2008
- Equianalgesic Dosing of OpioidsJournal of Pain & Palliative Care Pharmacotherapy, 2006
- Celiac Plexus BlockAnesthesiology, 2001
- Efficacy of Neurolytic Celiac Plexus Block in Varying Locations of Pancreatic CancerAnesthesiology, 2000
- Neurolytic Celiac Plexus Block for Treatment of Cancer PainAnesthesia & Analgesia, 1995